jaredwhitlock.bsky.social - Profile | ThreadSky | a Reddit-style client for Bluesky

Good piece from @andrewedunn.bsky.social on pharmaceutical CEOs "biting their tongues on defending some basic scientific principles, like vaccine safety, and institutions, like the NIH." endpts.com/post-hoc-pha...

submitted 2 days ago • 0 comments

Don't miss this deep dive on CRISPR's tremendous promise running up against disenchanted investors. It's a must-read. By @scienceboss.bsky.social endpts.com/biotech-is-s...

submitted 5 days ago • 0 comments

NEW: The Trump administration is exploiting a loophole to keep funding frozen at the NIH - a move that some legal scholars say is illegal. Federal Register notices are blocked, so no grant-review sessions can be scheduled. All the gritty details here, and a short 🧵: www.nature.com/articles/d41...

submitted 6 days ago • 4 comments

Drug giant Roche has long had a bad reputation in DNA sequencing. But no longer, it appears. Latest here: endpts.com/roche-no-lon...

submitted 6 days ago • 0 comments

Journo request: Our features editor @jaredwhitlock.bsky.social is after tips and stories:

submitted 10 days ago • 0 comments

Exclusive from @jaredwhitlock.bsky.social: Former FDA chief Robert Califf calls layoffs "haphazard, poorly thought-out." endpts.com/former-fda-c...

submitted 8 days ago • 0 comments

Robert Califf, the former head of the FDA, didn't mince words when I asked him about recent agency layoffs. endpts.com/former-fda-c...

submitted 8 days ago • 0 comments

I am the features editor at Endpoints News. We're closely reporting on the Trump administration slashing the federal workforce and the impact on biomedical research. I want to hear your stories and tips. Signal at: @jaredwhitlock.73. I can honor requests for anonymity.

submitted 11 days ago • 0 comments

Well, as I said a couple of weeks ago, thank God I'm not a CEO and I don't have to do this sort of dirty work. Because let's not kid around: if it has to do with the intersection of business and the Trump administration as it's been running so far, it's going to end up being dirty.

submitted 12 days ago • 0 comments

ARPA-H chief is out as Trump administration cuts health agencies endpts.com/arpa-h-chief...

submitted 12 days ago • 0 comments

Exclusive: Drugmakers plan Trump meeting next week amid Washington health shakeups, via @drewsnews.bsky.social endpts.com/drugmakers-p...

submitted 12 days ago • 0 comments

Looking to add science journalism to your feed? For over 40 years we've brought journalists to MIT to hone their craft. Now they're on Bluesky ⬇️ bsky.app/starter-pack...

submitted 15 days ago • 0 comments

Thomson Reuters has won the first major AI copyright case in the US. The decision has big implications for the battle between generative AI companies and rightsholders.

submitted 15 days ago • 44 comments

NIH plans to slash support for indirect research costs, sending shockwaves through science Capping these payments would ‘just grind our scientific complex to a halt,’ one researcher said www.statnews.com/2025/02/07/n...

submitted 19 days ago • 1 comment

New study will try to stop Alzheimer’s decades before it begins, using experimental Eli Lilly drug Good piece from Ryan Cross here at @endpts.com endpts.com/study-will-t...

submitted 22 days ago • 0 comments

For the first time ever, researchers will use an experimental drug to try and prevent Alzheimer's disease even before the first biological damage has been done. Ryan Cross has the inside story: endpts.com/study-will-t...

submitted 22 days ago • 0 comments

After the US targeted Chinese rivals to Illumina, it's no surprise that the company was included in tariff retaliations. More here on today's news and context on the geopolitical dynamic: endpts.com/illumina-add...

submitted 22 days ago • 0 comments

"Dark proteins." Also known as microproteins. There are thousands of them in our cells and we're still struggling to define their function. Succinctly reviewed @nature.com www.nature.com/articles/d41...

submitted 25 days ago • 10 comments

Private emails show RFK Jr. making false claims about Covid-19 shots, linking vaccines to autism www.statnews.com/2025/01/28/k...

submitted 29 days ago • 4 comments

Spatial multi-omics has just gone to the next level! www.nature.com/articles/s41... www.nature.com/articles/s41... —Integration of 5 omic modalities w/ spatial resolution at 20 -50 μm —"a new era for characterizing tissue & cellular heterogeneity that single-modality studies alone could not reveal"

submitted 30 days ago • 2 comments

ICYMI my latest in-depth piece: China's biotech boom is threatening US drugmakers' dominance I am continuing to closely report at the intersection of US and China. Feel free to get in touch with tips and ideas. endpts.com/chinas-drug-...

submitted 34 days ago • 1 comment

A little-known Chinese biotech startup has zipped ahead of US companies in one of the gene editing field’s most competitive races. endpts.com/chinese-star...

submitted 34 days ago • 0 comments

"The billionaire biotech firebrand, who has been Regeneron’s chief scientific officer since its founding 37 years ago, sees both AI and stem cells as examples of powerful tools that also suffer from over-the-top promises." Via @andrewedunn.bsky.social endpts.com/regeneron-cs...

submitted 35 days ago • 0 comments

Chinese drug developers are pursuing novel drug targets and hot therapeutic areas like obesity. The exploding trend has sent shocks through the biotech industry and its center of gravity, which has long been anchored in a handful of cities in the US. endpts.com/chinas-drug-...

submitted 36 days ago • 0 comments

My latest is an in-depth look at China's scientific rise unnerving the US biotech industry. A 🧵: endpts.com/chinas-drug-...

submitted 36 days ago • 1 comment

Great story by @wsjwernau.bsky.social about one effective way to help treat the mental health crisis. www.wsj.com/health/schiz...

submitted 66 days ago • 0 comments

My latest Post-Hoc provides some thoughts on the war for AI talent — in short why Big Pharma is losing that battle From reporting on the ground at NeurIPS to close out 2024: endpts.com/pharma-is-lo...

submitted 46 days ago • 1 comment

A baby boy born with a debilitating genetic disease will likely no longer require a liver transplant to stabilize his condition, thanks to an experimental treatment.

submitted 48 days ago • 0 comments

Balanced piece by David Wallace-Wells in NYT on the discovery of Ozempic, etc., based on Jeff Flier’s oral history from over the summer. (And as a bonus, it cites @ruxandrabio.bsky.social & Willy Chertman’s great new piece on “clinical trial abundance” too!). www.nytimes.com/2024/12/25/o...

submitted 63 days ago • 0 comments

Step one: get Timothée Chalamet on here.

submitted 63 days ago • 0 comments

The deal ends a months-long competition between two suitors that bid up the price of DNA sequencing company Singular. endpts.com/deerfield-to...

submitted 65 days ago • 0 comments

More details emerging about a new company founded by gene therapy pioneer Jim Wilson endpts.com/jim-wilsons-...

submitted 65 days ago • 1 comment

Really leaning into getting older. In the last hour I've complained that movie theaters are too loud now, read a physical newspaper and wondered why my knee hurts.

submitted 66 days ago • 0 comments

In 2024, I continued to report on rare disease medicine. Some highlights: For 3.5 years, I followed a teenager and his family while a custom treatment was developed for his seizures. The journey revealed a lot about personalized medicine's failures, and promise. endpts.com/a-teenager-f...

submitted 68 days ago • 1 comment

Also cut from the congressional bill is the reauthorization of the rare pediatric disease priority review voucher program which helps fund clinical trials & drug development at small companies working on rare diseases. And prescription drug insurance/PBM reform was cut as discussed yesterday #biosky

submitted 68 days ago • 0 comments

In this @endpts.com post-hoc analysis, I reflected on a year of reporting on the Biosecure Act. Even if the bill and its next incarnation fails, drugmakers are still weighing how closely to work with Chinese contractors. endpts.com/biosecure-ac...

submitted 70 days ago • 0 comments

Lots of good people and accounts in this starter pack for people in the biotech space

submitted 71 days ago • 0 comments

It's been really cool to see the accelerating migration to Bluesky. Check out our @endpts.com starter pack for editors / writers to follow. bsky.app/starter-pack...

submitted 71 days ago • 0 comments

An international panel says clinical microbiomes aren't ready for primetime...yet 🧬 🦠

submitted 71 days ago • 0 comments

This is a wild finding. Apparently the time of day a therapy is given to treat glioblastoma (brain tumour) can affect how well it works. neurosciencenews.com/glioblastoma...

submitted 75 days ago • 2 comments

Over 30 prominent scientists call for a ban on the creation of a "mirror cell"--a microbe made of molecules that are mirror images of their natural forms. It could cause a mind-boggling global disaster. Here's my story [gift link] 🧪https://nyti.ms/3OUCXp6

submitted 76 days ago • 96 comments